These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31242028)

  • 1. The Hardest Part.
    Schellinger IN; Mattern K; Raaz U
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1301-1306. PubMed ID: 31242028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease.
    Lacolley P; Regnault V; Segers P; Laurent S
    Physiol Rev; 2017 Oct; 97(4):1555-1617. PubMed ID: 28954852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix stiffness determines the phenotype of vascular smooth muscle cell in vitro and in vivo: Role of DNA methyltransferase 1.
    Xie SA; Zhang T; Wang J; Zhao F; Zhang YP; Yao WJ; Hur SS; Yeh YT; Pang W; Zheng LS; Fan YB; Kong W; Wang X; Chiu JJ; Zhou J
    Biomaterials; 2018 Feb; 155():203-216. PubMed ID: 29182961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Crosstalk between Vascular Smooth Muscle Cells and the Aged Extracellular Matrix.
    Ribeiro-Silva JC; Nolasco P; Krieger JE; Miyakawa AA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth muscle cell and arterial aging: basic and clinical aspects.
    Lacolley P; Regnault V; Avolio AP
    Cardiovasc Res; 2018 Mar; 114(4):513-528. PubMed ID: 29514201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension.
    Zhou N; Lee JJ; Stoll S; Ma B; Wiener R; Wang C; Costa KD; Qiu H
    Cardiovasc Res; 2017 Feb; 113(2):171-182. PubMed ID: 28003268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ1 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness.
    Zhu W; Kim BC; Wang M; Huang J; Isak A; Bexiga NM; Monticone R; Ha T; Lakatta EG; An SS
    Sci Rep; 2018 Feb; 8(1):2668. PubMed ID: 29422510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators.
    Yu CK; Xu T; Assoian RK; Rader DJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):164-173. PubMed ID: 29051139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage oligomeric matrix protein prevents vascular aging and vascular smooth muscle cells senescence.
    Wang M; Fu Y; Gao C; Jia Y; Huang Y; Liu L; Wang X; Wang W; Kong W
    Biochem Biophys Res Commun; 2016 Sep; 478(2):1006-13. PubMed ID: 27498005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition and other lifestyle influences on arterial aging.
    LaRocca TJ; Martens CR; Seals DR
    Ageing Res Rev; 2017 Oct; 39():106-119. PubMed ID: 27693830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging, ion channel expression, and vascular function.
    Toro L; Marijic J; Nishimaru K; Tanaka Y; Song M; Stefani E
    Vascul Pharmacol; 2002 Jan; 38(1):73-80. PubMed ID: 12378825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening.
    Jia G; Aroor AR; Martinez-Lemus LA; Sowers JR
    Curr Hypertens Rep; 2018 Jul; 20(9):76. PubMed ID: 29980951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.
    Durham AL; Speer MY; Scatena M; Giachelli CM; Shanahan CM
    Cardiovasc Res; 2018 Mar; 114(4):590-600. PubMed ID: 29514202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
    Owens GK; Kumar MS; Wamhoff BR
    Physiol Rev; 2004 Jul; 84(3):767-801. PubMed ID: 15269336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis.
    Orlandi A; Bochaton-Piallat ML; Gabbiani G; Spagnoli LG
    Atherosclerosis; 2006 Oct; 188(2):221-30. PubMed ID: 16487530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening.
    Liu SL; Bae YH; Yu C; Monslow J; Hawthorne EA; Castagnino P; Branchetti E; Ferrari G; Damrauer SM; Puré E; Assoian RK
    Sci Rep; 2015 Nov; 5():17189. PubMed ID: 26608672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly.
    Rubio-Ruiz ME; Pérez-Torres I; Soto ME; Pastelín G; Guarner-Lans V
    Ageing Res Rev; 2014 Nov; 18():132-47. PubMed ID: 25311590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression.
    Natoli AK; Medley TL; Ahimastos AA; Drew BG; Thearle DJ; Dilley RJ; Kingwell BA
    Hypertension; 2005 Nov; 46(5):1129-34. PubMed ID: 16230520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice.
    López-Andrés N; Calvier L; Labat C; Fay R; Díez J; Benetos A; Zannad F; Lacolley P; Rossignol P
    Hypertension; 2013 Jan; 61(1):120-9. PubMed ID: 23172930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.